Oral Intake of the Commercial Probiotic Blend Synbio<sup>®</sup> for the Management of Vaginal Dysbiosis.

J Clin Med · 2022 · PMC9821595 · PMID 36614828

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

According to the clinical results, all the Amsel criteria showed a decreasing trend at T1 sampling time, whereas an opposite tendency was detected at T2 ( Figure 2 ).

also in 47,180 other papers

an increasing trendno p-value reported

Compared to baseline (T0), the administration of SYNBIO ® for 15 days determined a statistically significant decrease in itching and vulvo-vaginal erythema/edema, whereas leucorrhea was characterized by an increasing trend.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.